Meyers Michael L. 4/A
4/A · Syndax Pharmaceuticals Inc · Filed Mar 25, 2019
Insider Transaction Report
Form 4/AAmended
Meyers Michael L.
SVP, Chief Development Officer
Transactions
- Purchase
Common Stock
2019-03-21$4.87/sh+8$39→ 7,230 total
Footnotes (1)
- [F1]Amendment filed to correct previously filed Form, which did not include 8 shares purchased in an additional transaction.